3SBio (HK:1530) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
3SBio’s subsidiary, Zhejiang Sunshine Mandi Pharmaceutical, achieved remarkable success during the 2024 ‘Double 11’ sales campaign. Its Mandi® brand topped multiple online platforms, including Tmall, JD Pharmacy, and TikTok Shop, in various OTC categories. This achievement highlights the brand’s strong market presence and potential growth in the pharmaceutical sector.
For further insights into HK:1530 stock, check out TipRanks’ Stock Analysis page.
